A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.
In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...
CLEVELAND, Ohio — Seven in 10 people now survive their cancer five years or longer, up from only half in the mid-1970s, ...
There's big cancer news this month. The American Cancer Society reports that for the first time, the five-year survival rate ...
Colorectal cancer has since jumped up from being the fifth-leading cancer death in the early 1990s.
Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...
A retrospective analysis finds that patients with lung-only metastatic pancreatic cancer have better overall survival, are ...
New American Cancer Society data show cancer survival rates hit 70%, but lung cancer remains the deadliest, and access to ...
Colon cancer is now the No. 1 cause of cancer deaths in Americans under 50. It claimed that spot seven years earlier than ...